Back
Results - Announcements
Sales rise 7.65% to Rs 41.22 crore
Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter
05-Nov-2024, 05:39
Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2024 as against Rs 7.32 crore during the previous quarter ended September 2023. Sales rose 7.65% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 38.29 crore during the previous quarter ended September 2023.
Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2024 as against Rs 7.32 crore during the previous quarter ended September 2023. Sales rose 7.65% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 38.29 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 41.22 | 38.29 | 8 |
| OPM % | 27.73 | 23.77 | - |
| PBDT | 13.16 | 10.13 | 30 |
| PBT | 12.52 | 9.54 | 31 |
| NP | 9.60 | 7.32 | 31 |
Powered by Capital Market - Live News